Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_assertion type Assertion NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_head.
- NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_assertion description "[In addition, we have observed the following: (i) HA/CD44-activated Rho kinase (ROK) mediates NHE1 phosphorylation and activity, and (ii) inhibition of ROK or NHE1 activity (by treating cells with a ROK inhibitor, Y27632, or NHE1 blocker, S-(N-ethyl-N-isopropyl) amiloride, respectively) blocks NHE1 phosphorylation/Na(+)-H(+) exchange activity, reduces intracellular acidification, eliminates the acidic environment in the extracellular matrix, and suppresses breast tumor-specific behaviors (e.g.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_provenance.
- NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_assertion evidence source_evidence_literature NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_provenance.
- NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_assertion SIO_000772 15090545 NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_provenance.
- NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_assertion wasDerivedFrom befree-20150227 NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_provenance.
- NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_assertion wasGeneratedBy ECO_0000203 NP674038.RAjH71nbsyLnaua_KsW2sph59hIfYxPsydJnDEPD8OlWo130_provenance.